{{item.name}}
${{item.price.price}}
Total
${{totalPrice}}
Continue to Checkout
Your cart is empty
A blood test recommended for the initial screening to detect both acute and primary infections of the HIV-1 and HIV-2 virus through the measurement of antibodies and antigens in the bloodstream.
HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, potentially leading to AIDS (Acquired Immunodeficiency Syndrome) if left untreated.
There are two main types of HIV: HIV-1 and HIV-2. While both types can lead to AIDS, there are some differences between the two in terms of progression and treatment.
eNational’s HIV-1 and HIV-2 test screens for both types of HIV through the detection of antibodies and antigens in the bloodstream. It also differentiates between HIV-1 and HIV-2, providing you with essential information for a tailored treatment strategy.
This highly sensitive fourth-generation test is able to detect HIV infection earlier than previous generations, usually within 2-4 weeks after exposure. *
This test is for anyone concerned about HIV exposure.
The CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once. People with certain risk factors should get tested more often.
This test screens for:
This is a combination test that detects HIV antibodies, produced by the body in response to HIV infection, and p24 antigen, a protein present in the HIV virus itself.
Early detection of HIV is crucial for timely intervention and treatment. Testing is the first step in maintaining your health and preventing HIV transmission.
While there is no cure for HIV, it can be controlled with treatment. For individuals with HIV, treatment is crucial to suppress the virus, preserve immune function, and reduce the risk of transmission to others.
* The timing of HIV detection can vary between individuals. Healthcare professionals often recommend testing again 3 months (12 weeks) after potential exposure.
$59.99
A blood test recommended for the initial screening to detect both acute and primary infections of the HIV-1 and HIV-2 virus through the measurement of antibodies and antigens in the bloodstream.